期刊文献+
共找到2,402篇文章
< 1 2 121 >
每页显示 20 50 100
Uterine rupture due to adenomyosis in an adolescent:A case report and review of literature
1
作者 Nah Ihm Kim Ji Shin Lee Jong Hee Nam 《World Journal of Clinical Cases》 SCIE 2023年第32期7888-7894,共7页
BACKGROUND Uterine rupture is a fatal medical complication with a high mortality rate.Most cases of uterine rupture occur in late pregnancy or during labor and are mainly related to uterine scarring due to previous su... BACKGROUND Uterine rupture is a fatal medical complication with a high mortality rate.Most cases of uterine rupture occur in late pregnancy or during labor and are mainly related to uterine scarring due to previous surgical procedures.Adenomyosis is a possible risk factor for uterine rupture.However,spontaneous uterine rupture due to severe adenomyosis in a non-gravida-teenaged female has not been reported in the literature to date.CASE SUMMARY A 16-year-old girl was referred to our hospital for acute abdominal pain and hypovolemic shock with a blood pressure of 90/50 mmHg.Radiologic studies revealed a huge endometrial mass with multiple nodules in the lung,suggesting lung metastasis.The patient underwent an emergency total hysterectomy and wedge resection of the lung nodules.Histologically,the uterus showed diffuse adenomyosis with glandular and stromal dissociation.Lung nodules were endometrioma with massive hemorrhage.Immunohistochemistry demonstrated that the tumor cells were positive for PAX8,ER,and PR expression,leading to a final diagnosis of pulmonary endometriosis and uterine adenomyosis.Following surgery,the patient remains in good condition without recurrence.CONCLUSION This is the first case of spontaneous uterine rupture due to adenomyosis in a nongravida adolescent. 展开更多
关键词 UTERUS adenomyosis MALIGNANCY ENDOMETRIOMA Case report
下载PDF
Adenomyosis uterine innervation in mice correlates to nerve growth factor expression,inflammation,and vascularization 被引量:9
2
作者 Yan Li Shaofen Zhang Xian Xia Shien Zou 《Neural Regeneration Research》 SCIE CAS CSCD 2010年第1期15-20,共6页
BACKGROUND: Studies have shown that abnormal innervation is an important factor impacting occurrence and development of pathological pain in endometriosis. OBJECTIVE: To observe uterine innervation of adenomyosis mice... BACKGROUND: Studies have shown that abnormal innervation is an important factor impacting occurrence and development of pathological pain in endometriosis. OBJECTIVE: To observe uterine innervation of adenomyosis mice and to analyze the cause of innervation changes due to nerve growth factor (NGF) expression, inflammation, and vascularization. DESIGN, TIME AND SETTING: This randomized, controlled, animal experiment was performed at the Research Institute of Obstetrics and Gynecology Hospital, and Central Laboratory of Zhong- shan Hospital, Fudan University from March to December 2008. MATERIALS: Tamoxifen was provided by Fudan Forward, China. Rabbit anti-mouse NGF was purchased from Santa Cruz Corporation, USA; rabbit anti-protein gene product 9.5 (PGP9.5) and rabbit antisubstance P (SP) were purchased from Chemicon, USA. METHODS: A total of 40 newborn ICR mice were randomly assigned to adenomyosis model and control groups, with 20 animals in each group. Mice in the adenomyosis model group were orally administrated 2.7 μmol/kg tamoxifen on days 2-5 after birth, while the controls were not treated. MAIN OUTCOME MEASURES: Both uteri from all mice were harvested at days 135-145 after birth. Expressions of polyclonal PGP9.5 and SP were immunohistochemically detected to demonstrate pan- and sensory nerve fibers. Microvessel density was quantified in the endometrium and myometrium using immunochemical staining for polyclonal rabbit anti-CD31, which stained vessels. Gene expression for NGF, high-affinity tyrosine kinase receptor (trkA), p75 neurotrophin receptor (p75NTR), bradykinin receptor-1 (BKR-1), and 2 (BKR-2), as well as substance P receptor (neurokinin1 receptor, NK1-R), were detected by reverse transcription-polymerase chain reaction. NGF-β protein expression was detected by Western blot analysis. RESULTS: More nerve fibers were stained with PGP9.5 in the endometrium and myometrium, and with SP in the endometrium, in adenomyosis mice compared with controls (P < 0.01 and P < 0.05). Microvessel density in the myometrium of adenomyosis mice was significantly greater than the controls (P < 0.01). In the uterus of adenomyosis mice, mRNA expression of NGF and its two receptors (trkA and p75 NTR), BKR-1, and NK1-R, as well as protein expression of NGF-β, were greater than the control mice (P < 0.01 or P < 0.05). CONCLUSION: Uterine innervation in the adenomyosis mice was increased compared with the controls. Moreover, NGF expression, inflammation, and vascularization, which have been shown to be impact factors of innervation, were abnormal in the uteri of adenomyosis mice. 展开更多
关键词 adenomyosis INNERVATION nerve growth factor INFLAMMATION VASCULARIZATION
下载PDF
Intrauterine cystic adenomyosis:Report of two cases 被引量:7
3
作者 Yan-Yan Fan Yi-Nan Liu +1 位作者 Jia Li Yan Fu 《World Journal of Clinical Cases》 SCIE 2019年第5期676-683,共8页
BACKGROUND Cystic adenomyosis is a special type of adenomyosis. Its clinical manifestations lack specificity. Pelvic ultrasound and nuclear magnetic resonance imaging can help clarify the diagnosis. Because cystic ute... BACKGROUND Cystic adenomyosis is a special type of adenomyosis. Its clinical manifestations lack specificity. Pelvic ultrasound and nuclear magnetic resonance imaging can help clarify the diagnosis. Because cystic uterine adenomyosis is rare in clinical work, it can be easily misdiagnosed or its diagnosis can be missed. Early surgical treatment and postoperative drug treatment can alleviate dysmenorrhea,menorrhagia, anemia, and other symptoms.CASE SUMMARY Two cases complained about abnormal vaginal bleeding and were diagnosed with intrauterine cystic adenomyosis by gynecological ultrasound and pathological examination. The clinical manifestations included dysmenorrhea,hypermenorrhea, and a history of cesarean section. Both cases underwent a surgery, and chocolate-like liquid was released from the cystic mass in the uterus and the manifestations were relieved.CONCLUSION Intrauterine cystic adenomyosis could be diagnosed by pathological examination and treated by hysterectomy or hystscopy to release the liquid inside. 展开更多
关键词 CYSTIC adenomyosis adenomyosis JUNCTIONAL ZONE INTRAUTERINE Case REPORT
下载PDF
Acute recurrent cerebral infarction caused by moyamoya disease complicated with adenomyosis:A case report 被引量:5
4
作者 Shao Zhang Li-Ming Zhao +5 位作者 Bing-Qian Xue Hao Liang Gao-Chao Guo Yang Liu Rui-Yu Wu Chao-Yue Li 《World Journal of Clinical Cases》 SCIE 2022年第14期4617-4624,共8页
BACKGROUND Moyamoya disease is essentially an ischemic cerebrovascular disease.Here,we describe a case of acute recurrent cerebral infarction caused by moyamoya disease with concurrent adenomyosis which,to our knowled... BACKGROUND Moyamoya disease is essentially an ischemic cerebrovascular disease.Here,we describe a case of acute recurrent cerebral infarction caused by moyamoya disease with concurrent adenomyosis which,to our knowledge,is the first in the literature.A literature review is also presented.CASE SUMMARY A 38-year-old female presented to the Research and Treatment Center of Moyamoya Disease in our hospital with"left limb weakness"as the main symptom.She was diagnosed with acute cerebral infarction and moyamoya disease through magnetic resonance imaging and digital subtraction angiography.Prior to this,she had experienced a prolonged menstrual period of one-month duration.This was investigated and adenomyosis was diagnosed.After passing the acute cerebral infarction phase,the patient underwent surgery for adenomyosis followed by combined cerebral revascularization.During the postoperative follow-up,improvements of the perfusion imaging stage and modified Rankin Scale were observed.A review of the literature showed only 16 reported cases of gynecological diseases complicated with stroke.The clinical characteristics,pathogenesis,therapeutic effects,and long-term prognosis of these cases have been studied and discussed.CONCLUSION In patients with moyamoya disease,early management of gynecological-related bleeding disorders is essential to prevent the complications of cerebral events. 展开更多
关键词 Moyamoya disease Combined cerebral revascularization Acute recurrent cerebral infarction Abnormal uterine bleeding adenomyosis Case report
下载PDF
Giant exophytic cystic adenomyosis with a levonorgestrel containing intrauterine device out of the uterine cavity after uterine myomectomy: A case report 被引量:3
5
作者 Yong Zhou Zheng-Yun Chen Xin-Mei Zhang 《World Journal of Clinical Cases》 SCIE 2020年第1期188-193,共6页
A cystic lesion arising from the myometrium of the uterus,termed as cystic adenomyosis,has chocolate-like,thick viscous contents and contains various amounts of endometrial stroma below the glandular epithelium.It is ... A cystic lesion arising from the myometrium of the uterus,termed as cystic adenomyosis,has chocolate-like,thick viscous contents and contains various amounts of endometrial stroma below the glandular epithelium.It is an extremely rare type of adenomyosis.CASE SUMMARY Herein,we report an unusual case of a giant cystic mass in the pelvic cavity after uterine myomectomy.The patient complained of abnormal uterine bleeding and severe dysmenorrhea.After a levonorgestrel-containing intrauterine device(LNG-IUD)was inserted,her symptoms were greatly alleviated.However,the LNG-IUD was detected in the cystic cavity during the follow-up.For fear of the intrauterine device migrating into and damaging the surrounding viscera,surgical treatment was proposed.Therefore,laparoscopic resection of the lesion and removal of the LNG-IUD were performed and cystic adenomyosis with an LNG-IUD out of the uterine cavity was diagnosed.CONCLUSION We believe that myomectomy breaking through the endometrial cavity may have been a predisposing factor for the development of cystic adenomyosis in this case. 展开更多
关键词 Cystic adenomyosis Dysmenorrhea Levonorgestrel containing intrauterine device MYOMECTOMY Case report
下载PDF
Ultrasound-guided microwave ablation for symptomatic adenomyosis:More areas of concern for more uniform and promising outcomes 被引量:4
6
作者 Huili Zhang Songyuan Yu Huixiong Xu 《Journal of Interventional Medicine》 2022年第3期122-126,共5页
Adenomyosis is a common gynecological disease in reproductive women,which causes serious dysmenorrhea,menorrhagia,anemia,and infertility,and has a serious impact on the physical and mental health of women.Considering ... Adenomyosis is a common gynecological disease in reproductive women,which causes serious dysmenorrhea,menorrhagia,anemia,and infertility,and has a serious impact on the physical and mental health of women.Considering that the efficacy of the traditional medication and surgical treatment is not ideal,an increasing number of patients are searching for more effective and less invasive therapies.Ultrasound(US)-guided microwave ablation(MWA)has emerged as a new effective and minimally invasive alternative treatment for symptomatic adenomyosis,and it is widely being used in clinical settings.Several studies have proven that it is an efficient and safe treatment modality for symptomatic adenomyosis,but a significant variance in clinical outcomes reported in previous studies was also observed.Herein,we have analyzed the potential causes of this problem from the aspects of the diagnosis of adenomyosis,symptom evaluation before ablation,steps of USguided ablation treatment,and outcome evaluation after ablation.Simultaneously,the clinical problems existing in the ablation treatment of adenomyosis are discussed,and the directions of future research are pointed out. 展开更多
关键词 Ultrasound-guided microwave ablation adenomyosis
下载PDF
Preoperative MRI Classification May Not Predict Symptom Relief after Uterine Artery Embolization in Patients with Adenomyosis 被引量:1
7
作者 Wen-bo GUO Si-qi HU +3 位作者 Ting-ting WAN Zhi-qiang WU Song CHEN Jian-yong YANG 《Current Medical Science》 SCIE CAS 2021年第6期1252-1256,共5页
Objective:To investigate the association between magnetic resonance imaging(MRI)classification and symptom relief after uterine artery embolization(UAE)in patients with adenomyosis.Methods:Totally,73 patients with sym... Objective:To investigate the association between magnetic resonance imaging(MRI)classification and symptom relief after uterine artery embolization(UAE)in patients with adenomyosis.Methods:Totally,73 patients with symptomatic adenomyosis who underwent UAE were retrospectively analyzed.Preoperative MRI classification was defined as:type Ⅰ,high signal on both T2-weighted images(T2WI)and T1-weighted images(T1WI);type Ⅱ,high signal only on T2WI,and type Ⅲ,high signal on neither T1WI nor T2WI.Dysmenorrhea was measured with the visual-analog scales and the degree of menorrhagia was measured according to the number of sanitary pads used in one menstrual cycle.Dysmenorrhea and menorrhagia were measured before UAE and 12 months after UAE.Results:The number of the type Ⅰ,Ⅱ,Ⅲ cases was 23,37,and 13,respectively.The baseline characteristics of the three groups exhibited no significant difference.The alleviation rates of dysmenorrhea among type Ⅰ,Ⅱ,Ⅲ cases were 73.9%,89.2%,and 84.6%,respectively(P=0.455).The alleviation rates of menorrhagia for type Ⅰ,Ⅱ,Ⅲ were 69.6%,78.4%,and 92.3%,respectively(P=0.714).Conclusion:Pre-procedure MRI classification and symptom relief after UAE exhibited no significant association.UAE has a favorable mid-term control on dysmenorrhea and menorrhagia among patients with adenomyosis.Preoperative MRI classification might not indicate symptom relief.More research is needed before changing clinical practice. 展开更多
关键词 adenomyosis symptoms magnetic resonance imaging prognosis uterine artery embolization
下载PDF
Association between etiopathogenesis of morbidly adherent placenta and adenomyosis
8
作者 Christopher A. Enakpene Ozgul Muneyyirci-Delale 《Open Journal of Obstetrics and Gynecology》 2012年第3期321-324,共4页
The association between etio-pathogenesis of morbidly adherent placenta (MAP) or placenta cretas and adenomyosis has never been described in medical literature. Contrary to the believe that MAP is due to direct invasi... The association between etio-pathogenesis of morbidly adherent placenta (MAP) or placenta cretas and adenomyosis has never been described in medical literature. Contrary to the believe that MAP is due to direct invasion of trophoblastic tissues into the adjacent normal myometrium due to prior uterine surgeries, this article describes how pre-existence of adenomyosis acts as a precursor for the development of placenta cretas. It elucidates how prior uterine traumas such as surgeries, repeated childbirths and endometritis cause endometrial tissues to invade the myometrium as a result of disruption of decidua basalis. The invaded endometrial tissues cause hyper-plasia and hypertrophy of surrounding myometrium to form the clinical entity called adenomyosis. The over-expression of bcl-2 oncogene in the endometrium causes inhibition of apoptosis of endometrial cells removing the barrier of trophoblastic tissues to invade the myometrium to form MAP. This hypothesis is based on the similarity of their clinical perspectives, similar pathological description of the two disease entities and their common molecular components. Both diseases increase with age;more in women older than 35 years and also in those with history of previous endometrial traumas such as surgeries, childbirth and endometritis. Both diseases also share common pathological factors and molecular components due to absence of deciduas basalis and over-expression of bcl-2 oncoprotein gene, inhibition of cell apoptosis and failure to find genetic abnormalities such as mutations of K-ras, P53 or LOH. An ongoing study looking at uterine specimens from cesarean hysterectomies and pelvic MRI evaluation of patients with retained placentas to prove that pre-existing adenomyosis may be a precursor to the development of morbidly adherent placenta is near to conclusion. 展开更多
关键词 Morbidly Adherent PLACENTA (Placenta Accretes) adenomyosis ASSOCIATION EPIDEMIOLOGY Etio-Pathogenesis and Clinical Perspective
下载PDF
Evaluation of the Impact of Laparoscopic Supracervical Hysterectomy for the Treatment of Adenomyosis on Pain Intensity and Patient Satisfaction
9
作者 Garri Tchartchian Harald Krentel +1 位作者 Bernd Bojahr Rudy L. De Wilde 《Surgical Science》 2018年第12期509-518,共10页
Objectives. Common symptoms of adenomyosis include pain and bleeding disorders and can severely impact a patient’s quality of life. Few studies report on the impact of hysteroscopy procedures on improving these sympt... Objectives. Common symptoms of adenomyosis include pain and bleeding disorders and can severely impact a patient’s quality of life. Few studies report on the impact of hysteroscopy procedures on improving these symptoms. This study evaluates the effect of laparoscopic supracervical hysterectomy (LASH) in adenomyosis patients on pain in general, pain during intercourse, bleeding disorders and general satisfactoriness of the procedure. Methods. This prospective observational single-arm, single-center study included 256 patients treated with LASH and whose histological analysis revealed adenomyosis. Other inclusion criteria were completed family planning and no more symptom relief with conservative therapy. They completed questionnaires before and after the procedure which evaluated pain in general, pain during intercourse, bleeding disorders and general satisfactoriness of the procedure. Results. Our results showed a significant (p Conclusion. As a minimal invasive procedure associated with low major complication rates, LASH is a qualified therapeutic choice to treat pain and bleeding disorders in adenomyosis patients with completed family planning and in where conservative therapy failed. 展开更多
关键词 HYSTERECTOMY LAPAROSCOPY ENDOMETRIOSIS adenomyosis LASH PAIN Management
下载PDF
Transcervical Interstitial Microwave Ablation Therapy for the Treatment of Adenomyosis: A Novel Alternative to Hysterectomy
10
作者 Yasushi Kanaoka Hirosumi Imoto 《Open Journal of Obstetrics and Gynecology》 2014年第14期840-845,共6页
Objectives: To investigate the clinical effects of transcervical interstitial microwave irradiation of adenomyotic tissues as an alternative to hysterectomy. Methods: Thirty-three patients who were candidates for hyst... Objectives: To investigate the clinical effects of transcervical interstitial microwave irradiation of adenomyotic tissues as an alternative to hysterectomy. Methods: Thirty-three patients who were candidates for hysterectomy for the treatment of adenomyosis associated with menorrhagia were treated by interstitial microwave irradiation using a specifically developed transabdominal ultrasound probe attachment for transcervical puncture along with microwave endometrial ablation, as an alternative to hysterectomy. Primary outcomes were changes in the venous hemoglobin level and the volume of the uterine body before and after treatment. Secondary outcomes were the visual-analogue scale (VAS) score for menorrhagia and dysmenorrhea after treatment. Results: At 3 months after surgery, the average hemoglobin level significantly increased by 4.6 g/dL. The volume of the uterine body significantly decreased to 53% and 52% of the volume before treatment at 3 and 12 months, respectively. VAS scores indicated an improvement in menorrhagia and dysmenorrhea. Conclusions: Transcervical interstitial microwave ablation therapy combined with microwave endometrial ablation reduced the uterine body volume and relieved menorrhagia and dysmenorrheal caused by adenomyosis. This strategy is a promising alternative to hysterectomy for the treatment of symptomatic adenomyosis. 展开更多
关键词 MICROWAVE Ablation adenomyosis Transcervical MENORRHAGIA DYSMENORRHEA
下载PDF
Pathogenesis and treatment status of adenomyosis complicated with infertility
11
作者 Hua Wang Chun-Hua Cao +2 位作者 Yan Chen Saili Wang Qin Wang 《TMR Integrative Medicine》 2019年第4期1-7,共7页
Adenomyosis (AD) refers to the endometrium (including glands and stroma) into myometrium gr owth of pathological changes, with the delay of women's childbea ring age, the pa ti ents with AD-associated infertility ... Adenomyosis (AD) refers to the endometrium (including glands and stroma) into myometrium gr owth of pathological changes, with the delay of women's childbea ring age, the pa ti ents with AD-associated infertility increased significantly. Although scholars disagreed about the effect of AD on infertility, more and more evidence showed that AD was closely related to the str uct ural and func ti onal defects of the eutopic endomet rium and myomet rial junc tional zone (MJZ), which may lead to embryo implantation failure and infertility. With the rapid development of imaging technology, the accuracy of diagnose AD has been enhanced, more and more infertility patients were diagnosed with AD. At the same time, a series of pathogenic hypothesis have been proposed to explain the relationship between AD. In addition, AD may influence the patient's reproductive function by affecting sperm transport, embryo implantation, altering uterine peristalsis, influencing the structure and function of endometrium, and changing the intrauterine environment. At present, the treatment of AD-associated infertility is similar to the treatment of AD. The commonly used treatment methods include drug therapy, conservative operative treatment, drug combination surgery, and Chinese medicine treatment and so on. The clinical and experimental studies of AD complicated with infertility and its possible pathogenesis and treatment in recent years are reviewed in this article. 展开更多
关键词 adenomyosis Infe rtility PATHOGENESIS Treatment Endomet rium
下载PDF
Effects of LNG-IUS combined with TCRE on ovarian function, MMP and related factors in patients with adenomyosis
12
作者 Sheng Li Hao Yan 《Journal of Hainan Medical University》 2017年第23期67-70,共4页
Objective: To observe the effect of combined therapy regimen on ovarian function, MMP and related factors in patients with adenomyosis under the condition of LNG-IUS drug therapy. Methods: A total of 110 patients with... Objective: To observe the effect of combined therapy regimen on ovarian function, MMP and related factors in patients with adenomyosis under the condition of LNG-IUS drug therapy. Methods: A total of 110 patients with adenomyosis from October 2015 to October 2017 were retrospectively analyzed and divided into control group and observation group. The control group of 54 patients, observation group of 56 patients. All patients were treated with LNG-IUS system in the 4th to 7th day of the menstrual cycle. The patients in the observation group were treated with TCRE on the basis of LNG-IUS. The fasting venous blood was taken from the third day of menstruation and the luteinizing hormone (LH (MMP-2, MMP-3, MMP-9) were detected by enzyme-linked immunosorbent assay (ELISA). The levels of VEGF, CA125 and IGF-1 were detected by enzyme-linked immunosorbent assay (ELISA) Ang-2, PGE2 levels were compared. Results: There was no significant difference in LH, FSH and E2 levels between the two groups before treatment. After treatment, the levels of LH, FSH and E2 were significantly higher in the two groups compared with those before treatment. (2) Before treatment, the levels of serum MMP-2, MMP-3, MMP-2 and MMP-2 in the two groups were significantly higher than those in the control group. The levels of MMP-2, MMP-3 and MMP-9 in the serum of the two groups were significantly lower than those before treatment, and there was no significant difference between the two groups. (3) Before treatment, serum levels of VEGF, CA125, IGF-1, Ang-2 and PGE2 in the two groups were significantly lower than those in the control group. The levels of serum VEGF, CA125, IGF-1, Ang-2 and PGE2 in the two groups were significantly lower than those before treatment. The patients in the observation group were significantly lower than the control group, there was significant difference between the two groups. Conclusion The levels of serum MMP-2, MMP-3, MMP-9 and VEGF, CA125, IGF-1, Ang-2 and MMP-2 in patients with adenomyosis were treated with TCRE on the basis of LNG-IUS drug therapy. PGE2 level, indicating that TCRE combined with LNG-IUS drug therapy can not only improve the efficacy, improve the patient's menstrual flow, dysmenorrhea and other symptoms, control the progression of the disease, but also by regulating the expression of certain factors play a role in improving ovarian function, worthy of clinical On the promotion and application. 展开更多
关键词 adenomyosis OVARIAN function MMP LNG-IUS TCRE
下载PDF
Clinical Efficacy of Dienogest and Levonorgestrel-Releasing Intrauterine System in the Treatment of Adenomyosis
13
作者 Yang Xu Li Li Guixia Yang 《Journal of Clinical and Nursing Research》 2022年第5期141-145,共5页
Objective:To compare the clinical efficacy and adverse reactions of dienogest and levonorgestrel-releasing intrauterine system in the treatment of adenomyosis.Methods:A total of 60 cases of adenomyosis admitted to Dez... Objective:To compare the clinical efficacy and adverse reactions of dienogest and levonorgestrel-releasing intrauterine system in the treatment of adenomyosis.Methods:A total of 60 cases of adenomyosis admitted to Dezhou Women and Children’s Hospital from January 2020 to October 2021 were selected and randomly divided into two groups(Group A and Group B),which were initiated on dienogest and levonorgestrel-releasing intrauterine system,respectively.The therapeutic effects and adverse reactions of the two groups were analyzed.Results:After 6 months of treatment,the uterine volume in the LNG-IUS group reduced slightly compared with that before treatment,with no statistical significance(p>0.05),while that in the DNG group increased slightly compared with that before treatment,with no statistical significance(p>0.05).After 6 months of treatment,the hemoglobin of patients in both groups increased compared with that before treatment;there was no significant difference in the DNG group(p>0.05),but there was significant difference in the LNG-IUS group(p<0.01).After 6 months of treatment,the VAS scores of the two groups were significantly lower than those before treatment(p<0.01);the serum CA125 level in both groups decreased significantly compared with that before treatment(p<0.01).Conclusion:Mirena(levonorgestrel-releasing intrauterine system)has better therapeutic effect on adenomyosis and fewer adverse reactions than deinogest. 展开更多
关键词 adenomyosis Deinogest Levonorgestrel-releasing intrauterine system Clinical efficacy
下载PDF
Evaluating the clinical efficacy of Thunder-Fire moxibustion combined with ovulation monitoring in the treatment of adenomyosis combined with infertility
14
作者 Hua Wang Yan Chen +6 位作者 Yong Yin Chun-Hua Cao Sai-Li Wang Qin Wang De-Xi Peng Chun-Jian Zhu Lin-Wei Chen 《Traditional Medicine Research》 2018年第5期243-250,共8页
目的:评价雷火灸联合排卵监测治疗子宫腺肌病合并不孕的临床疗效。方法:选择诊断符合子宫腺肌病合并不孕且中医辨证属于寒凝血瘀(具有经前综合症或经期下腹冷痛,得热痛减,肢端冰冷等临床表现)的患者120例,随机分为治疗组和对照组,每组... 目的:评价雷火灸联合排卵监测治疗子宫腺肌病合并不孕的临床疗效。方法:选择诊断符合子宫腺肌病合并不孕且中医辨证属于寒凝血瘀(具有经前综合症或经期下腹冷痛,得热痛减,肢端冰冷等临床表现)的患者120例,随机分为治疗组和对照组,每组各60例。治疗组予雷火灸联合排卵监测,对照组单纯予排卵监测,比较两组6个月经周期内的妊娠率,痛经和中医证候群的改善情况以及血清癌抗原125的水平。结果:治疗组6个月经周期内妊娠率与对照组相比有统计学意义(50.0%vs 23.3%,P=0.021)。与对照组相比,治疗组痛经与中医证候群改善明显(分别为3.87±2.03 vs.5.70±1.01,P=0.002 and 7.33±4.11 vs.10.52±2.33,P=0.006)。两组相比血清癌抗原125的水平有显著性差异(55.45±14.65 vs 63.34±11.41,P=0.031)。但是子宫平均直径与对照组相比差异无统计学意义(67.13±7.59 vs.69.89±5.30,P=0.137)。结论:雷火灸联合排卵监测能有效地提高子宫腺肌症不孕患者的受孕率。 展开更多
关键词 子宫腺肌病 不孕 雷火灸 排卵监测 妊娠率 痛经
下载PDF
Influence of assisted reproductive technology and uterine leiomyoma on pregnancy outcomes in women with adenomyosis
15
作者 Yi-Ling Wang Zhao Tian +2 位作者 Xiao-Hong Chang Hong-Lan Zhu Heng Cui 《Gynecology and Obstetrics Clinical Medicine》 2023年第1期56-59,共4页
Aim To assess whether adverse pregnancy outcomes in women with adenomyosis are different according to the method of conception and the concurrent of uterine leiomyoma(UL).Methods We performed a retrospective study.Fif... Aim To assess whether adverse pregnancy outcomes in women with adenomyosis are different according to the method of conception and the concurrent of uterine leiomyoma(UL).Methods We performed a retrospective study.Fifty-three singleton pregnancy cases complicated with adenomyosis were included in this study.In the study group,15 women became pregnant with assisted reproductive technology(ART)and 21 women combined with UL.Pregnancy outcomes were compared between ART and non-ART,UL and non-UL groups.Results The prevalence for such complications as hypertensive disorder complicating pregnancy(HDCP)and postpartum hemorrhage(PPH)were significantly higher in the women conceived by ART(33.3%vs.5.3%,P​=​0.023)and(53.3%vs.23.7%,P​=​0.037),respectively.And women concurrent with UL of which the diameter≥4​cm were more likely to have severe PPH(44.4%vs.0%,P​=​0.021).Conclusion ART may increase the risk of adverse pregnancy outcomes such as HDCP and PPH in women with adenomyosis and UL of which the diameter≥4​cm may further increase the risk of severe PPH. 展开更多
关键词 adenomyosis Adverse pregnancy outcomes Assisted reproductive technology Uterine leiomyoma
原文传递
地诺孕素治疗子宫腺肌病疗效与安全性meta分析
16
作者 张毅 张瑞 +2 位作者 张俊珂 郝洁 刘克锋 《现代妇产科进展》 2024年第5期345-351,共7页
目的:系统评价地诺孕素治疗子宫腺肌病的疗效及安全性,为临床用药提供循证依据。方法:计算机检索PubMed、EMbase、Cochrane Library、中国生物医学文献数据库、CNKI和万方数据库,检索时限均为建库至2023年7月30日,纳入地诺孕素(试验组)... 目的:系统评价地诺孕素治疗子宫腺肌病的疗效及安全性,为临床用药提供循证依据。方法:计算机检索PubMed、EMbase、Cochrane Library、中国生物医学文献数据库、CNKI和万方数据库,检索时限均为建库至2023年7月30日,纳入地诺孕素(试验组)对比阳性药物或安慰剂(对照组)治疗子宫腺肌病的随机对照研究(RCT)。筛选文献、提取资料后采用Cochrane 5.1.0偏倚风险评估工具对纳入文献质量进行评价,采用Rev Man 5.3统计软件进行meta分析。结果:纳入10篇RCT研究,共820例患者。Meta分析结果显示,试验组较对照组VAS评分显著降低(SMD=-2.50,95%CI为-4.73~-0.27,P=0.03),对于子宫体积变化疗效相当(MD=0.24,95%CI为-0.87~1.36,P=0.67),试验组的临床有效率显著高于对照组(RR=1.30,95%CI为1.19~1.41,P<0.01),患者的CA125水平两者差异不大(MD=-4.25,95%CI为-13.16~4.66,P=0.35),两者的潮热副反应发生率(RR=0.72,95%CI为0.03~15.53,P=0.83)、异常子宫出血发生率(RR=2.11,95%CI为0.87~5.15,P=0.10)相当。结论:地诺孕素组的疼痛缓解较安慰剂组有明显优势,与阳性对照组相比,疗效差别不大;临床有效率显著高于阳性对照组,子宫体积变化、CA125水平与阳性对照组和安慰剂组疗效均相当;安全性方面,潮热副反应发生率与阳性对照组和安慰剂组均相当,异常子宫出血的发生率与阳性对照组相当,但显著高于安慰剂组,因此应用地诺孕素时要警惕子宫出血的风险。未来仍需大规模随机对照研究去验证。 展开更多
关键词 地诺孕素 子宫腺肌病 META分析
下载PDF
Pyomyoma as a Complication of Uterine Artery Embolization (A Case Report)
17
作者 Abrar Tooq Layla Rafeei +3 位作者 Nusrat Kazi Safa Hussain Mohamed Al-Tabban Mariam Mahmood 《Open Journal of Obstetrics and Gynecology》 2024年第1期29-35,共7页
Pyomoyoma is a rare complication of Uterine Artery Embolization (UAE). This case report reflects on this condition. A 45-year-old female, a known case of adenomyosis, presented with intermittent fever and foul vaginal... Pyomoyoma is a rare complication of Uterine Artery Embolization (UAE). This case report reflects on this condition. A 45-year-old female, a known case of adenomyosis, presented with intermittent fever and foul vaginal discharge. These symptoms occurred shortly after the patient underwent UAE for menorrhagia secondary to adenomyosis. Computed tomography scan of the abdomen and pelvis aided in the diagnosis of Pyomyoma secondary to UAE. After a trial of broad spectrum antibiotics and Suction and Evacuation of the uterus had little to no help in the patient’s condition, she underwent Total Abdominal Hysterectomy in which a big, organized pus collection was removed from the uterus. Conclusion: Pyomyoma should be considered in the differentials for patients presenting with fever and vaginal discharge post UAE. 展开更多
关键词 Pyomyoma Uterine Artery Embolization adenomyosis
下载PDF
基于生物信息学方法的子宫腺肌病关键靶点与中药筛选研究
18
作者 杨书彬 练晓梅 +2 位作者 师伟 裴晨晨 孙健 《生殖医学杂志》 CAS 2024年第2期216-228,共13页
目的通过数据挖掘结合生物信息学技术,比较子宫腺肌病患者与正常人群的基因芯片数据库,查询差异基因,并分析差异基因参与的生物过程和潜在靶点,预测治疗子宫腺肌病的潜在药物。方法利用基因表达数据库(GEO)筛选出GSE78851和GSE7307两个... 目的通过数据挖掘结合生物信息学技术,比较子宫腺肌病患者与正常人群的基因芯片数据库,查询差异基因,并分析差异基因参与的生物过程和潜在靶点,预测治疗子宫腺肌病的潜在药物。方法利用基因表达数据库(GEO)筛选出GSE78851和GSE7307两个数据集,通过GEO2R分析芯片的共有差异基因,应用Omicshare制作差异基因热图,借助DAVID数据库对差异基因进行基因本体分析(GO)和京都基因与基因组百科全书(KEGG)分析,使用String构建蛋白质-蛋白质相互作用网络,筛选核心基因,再进一步利用Cytoscape 3.9.0的MCODE插件对差异表达基因进行模块分析。通过医学本体信息检索平台筛选治疗子宫腺肌病的中医药物。结果筛选出433个共有差异基因,差异表达基因主要富集在细胞黏附、对雌二醇的反应、细胞凋亡等生物过程和氧化磷酸化、雌激素信号通路、PI3K-Akt等信号通路。共得出p53蛋白(TP53)、细胞色素C(CYCS)、肌动蛋白(ACTB)、Ⅳ型胶原酶(MMP2)、雌激素受体(ESR1)、CD44、丝裂原活化蛋白激酶3(MAPK3)、胰岛素样生长因子-Ⅰ(IGF-Ⅰ)、细胞质动力蛋白1重链1(DYNC1H1)、血小板反应蛋白-1(THBS1)、细胞色素氧化酶4Ⅱ(COX4Ⅱ)、NDUFAB1、人原纤维蛋白-1(FBN1)、ATP5A1、NDUFB7、ATP5G1等16个核心基因。在Cytoscape 3.9.0中进行模块分析并得出两个重要模块,对其进行分析后发现模块1基因主要与氧化磷酸化信号通路相关,模块2基因主要与Rap1、Wnt信号通路相关。筛选得到丹参、当归、茯苓、三七、厚朴花、茶树根、蚕砂7味出现频次最高的中药。结论通过差异表达基因和富集分析得到的生物过程与信号通路可以为子宫腺肌病的潜在治疗靶点提供参考,通过核心基因映射得到了治疗子宫腺肌病的潜在药物,为子宫腺肌病的治疗提供新的思路。 展开更多
关键词 子宫腺肌病 数据挖掘 差异基因 蛋白质-蛋白质相互作用 模块分析
下载PDF
张婷婷治疗子宫腺肌症痛证经验
19
作者 曾薇薇 陆黎娟 +3 位作者 黄圣惠 李盼盼 郑徐 张婷婷 《辽宁中医杂志》 CAS 北大核心 2024年第2期57-60,共4页
子宫腺肌症的发病率逐年上升,其治疗是临床的难点。张婷婷教授治疗子宫腺肌症痛证,根据“瘀阻于内,不通则痛”的基本病机,口服汤剂采用“柴芍方”以疏肝行气、活血止痛;“红藤方”以清热凉血、散瘀止痛;“清瘀温通方”以寒温并用、化瘀... 子宫腺肌症的发病率逐年上升,其治疗是临床的难点。张婷婷教授治疗子宫腺肌症痛证,根据“瘀阻于内,不通则痛”的基本病机,口服汤剂采用“柴芍方”以疏肝行气、活血止痛;“红藤方”以清热凉血、散瘀止痛;“清瘀温通方”以寒温并用、化瘀止痛;“扶正祛瘀方”以益气扶正、祛瘀止痛。张婷婷临证还结合灌肠、足浴的方法,内外合治,长期管理患者,效果显著。 展开更多
关键词 子宫腺肌症 痛证 中医药 张婷婷 名医经验
原文传递
高强度聚焦超声消融联合屈螺酮炔雌醇片治疗子宫腺肌病患者的临床疗效及对血管生成因子和子宫动脉血流动力学的影响
20
作者 李莉 刘春桃 +2 位作者 刘杨 刘明盛 李丽 《疑难病杂志》 CAS 2024年第5期599-604,共6页
目的探究高强度聚焦超声(HIFU)消融联合屈螺酮炔雌醇片治疗子宫腺肌病(AD)患者的效果及对血管生成因子和子宫动脉血流动力学的影响。方法选取2021年2月—2023年2月成都市第五人民医院妇产科诊治的AD患者104例为研究对象,利用随机数字表... 目的探究高强度聚焦超声(HIFU)消融联合屈螺酮炔雌醇片治疗子宫腺肌病(AD)患者的效果及对血管生成因子和子宫动脉血流动力学的影响。方法选取2021年2月—2023年2月成都市第五人民医院妇产科诊治的AD患者104例为研究对象,利用随机数字表法分为单一组(n=52)和联用组(n=52)。单一组采用HIFU消融治疗,联用组在单一组的基础上继续服用屈螺酮炔雌醇片治疗,治疗12周后,比较2组的临床疗效、血清血管生成因子[血管生成素-2(Ang-2)、血管内皮生长因子(VEGF)、脂联素(ADPN)]、卵巢相关指标[雌激素(E 2)、促卵泡激素(FSH)、抗苗勒管激素(AMH)、黄体生成素(LH)]水平、子宫动脉血流动力学[(血流速度峰值(PSV)、舒张期末血流速度(EDV)、搏动指数(PI)、阻力指数(RI)]、子宫体积、病灶体积及直径、临床症状(月经周期变化、经期延长、经血成块、月经量增多、日间尿频、乏力、痛经、盆腔疼痛、夜间尿频)评分以及不良反应发生率。结果联用组治疗总有效率高于单一组(90.38%vs.75.00%,χ^(2)/P=4.300/0.038);治疗后2组的Ang-2、VEGF、E 2、AMH、FSH、LH、PSV、EDV、RI、子宫体积、病灶体积、病灶直径水平、临床症状评分均较治疗前降低,且联用组低于单一组(t/P=3.340/0.001、5.125/<0.001、4.427/<0.001、9.381/<0.001、2.313/0.023、9.795/<0.001、3.149/0.002、3.584/0.001、2.139/0.035、4.151/<0.001、15.493/<0.001、8.814/<0.001、6.605/<0.001、4.583/<0.001、9.112/<0.001、7.522/<0.001、5.427/<0.001、3.425/0.001、4.084/<0.001、8.209/<0.001);治疗后2组的ADPN、PI较治疗前升高,且联用组显著高于单一组(t/P=2.659/0.002、2.801/0.006);2组患者的不良反应总发生率比较差异无统计学意义(P>0.05)。结论AD患者经HIFU消融联合屈螺酮炔雌醇治疗后临床症状显著改善,其血管生成因子、血流动力学水平显著降低,安全性较高。 展开更多
关键词 子宫腺肌病 高强度聚焦超声消融 屈螺酮炔雌醇 血流动力学 血管生成因子
下载PDF
上一页 1 2 121 下一页 到第
使用帮助 返回顶部